Sublingual immunotherapy reduces symptoms of asthma and hay fever, systematic review finds

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f2056 (Published 2 April 2013)
Cite this as: BMJ 2013;346:f2056

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Sophie Ramsey
  1. 1BMJ

Researchers have found strong evidence that sublingual immunotherapy improves the symptoms of asthma and moderate evidence that it decreases those of rhinitis and rhinoconjunctivitis.

The researchers, from Johns Hopkins University in Baltimore, carried out a systematic review of the literature to assess the effectiveness and safety of aqueous sublingual immunotherapy for rhinitis and asthma.1 They found 63 randomised controlled trials that compared sublingual immunotherapy with placebo, pharmacotherapy, or other sublingual immunotherapy regimens. These studies …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL